A. Kahn

发表

Hepatocyte Nuclear Factor-4α Involved in Type 1 Maturity-Onset Diabetes of the Young Is a Novel Target of AMP-Activated Protein Kinase

B. Viollet, S. Vaulont, I. Leclerc, 2001 .

Upstream Stimulatory Factor-2 (USF2) Activity Is Required for Glucose Stimulation of L-Pyruvate Kinase Promoter Activity in Single Living Islet β-Cells*

H. Kennedy, B. Viollet, G. Rutter, 1997, The Journal of Biological Chemistry.

Transfection of hepatic genes into adult rat hepatocytes in primary culture and their tissue-specific expression.

A. Kahn, J. Decaux, F. Ginot, 1989, European journal of biochemistry.

Illegitimate transcription: transcription of any gene in any cell type.

J. Concordet, J. Kaplan, J. Chelly, 1989, Proceedings of the National Academy of Sciences of the United States of America.

A Novel CNS Gene Required for Neuronal Migration and Involved in X-Linked Subcortical Laminar Heterotopia and Lissencephaly Syndrome

Y. Berwald‐Netter, P. Billuart, A. Koulakoff, 1998, Cell.

Expression of the rat aldolase B gene: a liver-specific proximal promoter and an intronic activator.

A. Kahn, J. Decaux, F. Ginot, 1991, Biochemical and biophysical research communications.

In Vivo Functional Characterization of the Aldolase B Gene Enhancer*

A. Kahn, A. Porteu, C. Gregori, 2002, The Journal of Biological Chemistry.

Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine

Pierre Laurent-Puig, P. Laurent-Puig, A. Kahn, 2005, Development.

Dystrophin gene transcribed from different promoters in neuronal and glial cells

Y. Berwald‐Netter, A. Koulakoff, J. Kaplan, 1990, Nature.

Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation

H. R. Crollius, P. Billuart, J. Fryns, 1998, Nature.

Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.

T. van Dyke, T. Dyke, A. Kahn, 1999, Cancer research.

Retrovirus-mediated enzymatic correction of Tay-Sachs defect in transduced and non-transduced cells.

A. Kahn, L. Poenaru, L. Castelnau-Ptakhine, 1998, Human molecular genetics.

Muscle phosphofructokinase deficiency in man: expression of the defect in blood cells and cultured fibroblasts

D. Weil, A. Kahn, J. Dreyfus, 1981, Annals of human genetics.

Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy.

J. Melki, A. Kahn, C. Cifuentes-Díaz, 2003, Human molecular genetics.

Cis-regulation of the L-type pyruvate kinase gene promoter by glucose, insulin and cyclic AMP.

M. Díaz-Guerra, A. Kahn, M. Raymondjean, 1992, Nucleic acids research.

Transcriptional Glucose Signaling through The Glucose Response Element Is Mediated by the Pentose Phosphate Pathway (*)

Ruihuan Chen, A. Kahn, M. Cuif, 1996, The Journal of Biological Chemistry.

Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts.

A. Kahn, M. Morris, A. Fernandez, 1996, Molecular biology of the cell.

Bcl-2 and Bax Modulate Adenine Nucleotide Translocase Activity 1

M. Prevost, G. Kroemer, P. Petit, 2003 .

Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice.

S. Vaulont, A. Kahn, G. Nicolas, 2005, Blood.

Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis.

A. Kahn, S. Gautron, J. Dreyfus, 1987, The Journal of clinical investigation.

Localization of aldolase C mRNA in brain cells

Y. Berwald‐Netter, A. Kahn, T. Popovici, 1990, FEBS letters.

Estradiol-dependent uterine leiomyomas in transgenic mice.

A. Kahn, A. Vandewalle, M. Thomasset, 1996, The Journal of clinical investigation.

Characterization of a highly complex region in Xq13 and mapping of three isodicentric breakpoints associated with preleukemia.

A. Monaco, J. Ramser, R. Reinhardt, 2000, Genomics.

Transcriptional and translational mechanisms of cytochrome b5 reductase isoenzyme generation in humans.

A. Kahn, A. Leroux, L. Mota Vieira, 2001, The Biochemical journal.

Fast-muscle-specific DNA-protein interactions occurring in vivo at the human aldolase A M promoter are necessary for correct promoter activity in transgenic mice

A. Kahn, M. Salminen, P. Maire, 1996, Molecular and cellular biology.

L-type pyruvate kinase from human liver. Purification by double affinity elution, electrofocusing and immunological studies.

J. Marie, A. Kahn, P. Boivin, 1976, Biochimica et biophysica acta.

Expression of COUP-TFII in metabolic tissues during development

M. Vasseur-Cognet, I. Leclerc, A. Kahn, 2002, Mechanisms of Development.

Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors

B. Pettmann, H. Schmalbruch, A. Kahn, 1997, Nature Medicine.

Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin.

A. Kahn, M. Peuchmaur, A. Vandewalle, 1999, Cancer research.

A ubiquitous enhancer shared by two promoters in the human aldolase A gene.

J. Concordet, A. Kahn, P. Maire, 1991, Nucleic acids research.

In vivo effects of activated H‐ras oncogene expressed in the liver and in urogenital tissues

M. Tulliez, F. Terzi, A. Kahn, 1997 .

Diet-dependent carcinogenesis of pancreatic islets and liver in transgenic mice expressing oncogenes under the control of the L-type pyruvate kinase gene promoter.

M. Tulliez, G. Grimber, P. Briand, 1992, Oncogene.

Oligophrenin 1 encodes a rho-GAP protein involved in X-linked mental retardation.

P. Billuart, J. Chelly, C. Moraine, 1998, Pathologie-biologie.

Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease.

A. Kahn, C. Caillaud, L. Poenaru, 1998, American journal of human genetics.

Glucose-stimulated genes and prospects of gene therapy for type I diabetes.

Ruihuan Chen, A. Kahn, R. Chen, 1997, Endocrine reviews.

Bone marrow transplantation in mice leads to a minor population of hepatocytes that can be selectively amplified in vivo

L. Rénia, A. Kahn, V. Mallet, 2002, Hepatology.

Corticosteroid-dependent sodium transport in a novel immortalized mouse collecting duct principal cell line.

A. Kahn, B. Rossier, A. Vandewalle, 1999, Journal of the American Society of Nephrology : JASN.

Transcriptional regulation by glucose in the liver.

A. Kahn, 1997, Biochimie.

Adenoviral and adeno-associated viral vector mediated gene transfer in the guinea pig cochlea

M. Ulfendahl, A. Kahn, M. Mezzina, 2002, Neuroreport.

Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation.

C. Walsh, H. Bokhoven, J. Fryns, 2000, American journal of medical genetics.

Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response.

P. Briand, A. Kahn, D. Duboc, 1995, Human gene therapy.

Dietary and hormonal regulation of aldolase B gene expression.

A. Munnich, G. Reach, S. Vaulont, 1985, The Journal of clinical investigation.

Expression of the gene for anti-M\l=u"\llerian hormone

S. Mader, A. Kahn, L., 2008 .

A null allele frequent in non-Jewish Tay-Sachs patients

J. Chelly, A. Kahn, L. Poenaru, 1993, Human Genetics.

Conditional cell ablation by tight control of caspase-3 dimerization in transgenic mice

A. Kahn, V. Mallet, D. Arnoult, 2002, Nature Biotechnology.

Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice.

A. Kahn, C. Perret, A. Porteu, 1999, American journal of physiology. Gastrointestinal and liver physiology.

Bcl-2 targeted overexpression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors.

A. Kahn, P. Mayeux, A. Porteu, 1997, Blood.

Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions.

A. Kahn, A. Vandewalle, A. Porteu, 1996, Gene expression.

Identification and Functional Characterization of an Erythroid-specific Enhancer in the L-type Pyruvate Kinase Gene (*)

A. Kahn, M. Raymondjean, A. Porteu, 1995, The Journal of Biological Chemistry.

RT-PCR and mRNA Quantitation

J. Chelly, A. Kahn, 1994 .

Heterogeneity of the rat NADH-cytochrome-b5-reductase transcripts resulting from multiple alternative first exons.

J. Kaplan, A. Kahn, A. Leroux, 1994, European journal of biochemistry.

An opportunistic promoter sharing regulatory sequences with either a muscle-specific or a ubiquitous promoter in the human aldolase A gene

J. Concordet, A. Kahn, M. Salminen, 1993, Molecular and cellular biology.

The 5′‐AMP‐activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex

I. Leclerc, A. Kahn, B. Doiron, 1998, FEBS letters.

Regulation of the expression of the L-type pyruvate kinase gene in adult rat hepatocytes in primary culture.

A. Kahn, J. Decaux, B. Antoine, 1989, The Journal of biological chemistry.

Adenoviral Vector as a Gene Delivery System into Cultured Rat Neuronal and Glial Cells

M. Perricaudet, Y. Berwald‐Netter, A. Koulakoff, 1993, The European journal of neuroscience.

Long-term histological follow-up of genetically modified myoblasts grafted into the brain.

M. Peschanski, F. Lisovoski, A. Kahn, 1997, Brain research. Molecular brain research.

Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy.

B. Pettmann, A. Hagège, H. Schmalbruch, 1999, The Journal of clinical investigation.

Long–term correction of mouse dystrophic degeneration by adenovirus–mediated transfer of a minidystrophin gene

M. Perricaudet, J. Kaplan, P. Briand, 1993, Nature genetics.

Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries.

X. Bertagna, A. Kahn, F. Lenne, 1985, The Journal of clinical investigation.

Glucose Regulation of Gene Transcription*

M. Vasseur-Cognet, S. Vaulont, A. Kahn, 2000, The Journal of Biological Chemistry.

Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase.

B. Viollet, S. Vaulont, I. Leclerc, 2001, Diabetes.

Proopiomelanocortin gene expression in normal and tumoral human lung.

D. Vieau, X. Bertagna, A. Kahn, 1991, The Journal of clinical endocrinology and metabolism.

Overproduction of a truncated hepatocyte nuclear factor 3 protein inhibits expression of liver-specific genes in hepatoma cells

A. Kahn, A. Vandewalle, P. Chafey, 1995, Molecular and cellular biology.

Pituitary-like proopiomelanocortin transcripts in human Leydig cell tumors.

D. Vieau, X. Bertagna, A. Kahn, 1990, The Journal of clinical investigation.

Role of AMP-activated protein kinase in the regulation by glucose of islet beta cell gene expression.

G. Rutter, D. Hardie, G. da Silva Xavier, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Glucose‐dependent regulation of the l‐pyruvate kinase gene in a hepatoma cell line is independent of insulin and cyclic AMP

M. Díaz-Guerra, A. Kahn, B. Antoine, 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Respective roles of glucose, fructose, and insulin in the regulation of the liver-specific pyruvate kinase gene promoter.

A. Kahn, M. Cuif, M. Diaz-Guerra, 1994, The Journal of biological chemistry.

Role of the GLUT 2 Glucose Transporter in the Response of the L-type Pyruvate Kinase Gene to Glucose in Liver-derived Cells*

A. Kahn, A. Leturque, A. Vandewalle, 1997, The Journal of Biological Chemistry.

A tamoxifen‐inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver

M. Vasseur-Cognet, S. Vaulont, A. Kahn, 2002, Hepatology.

Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas.

M. Tulliez, A. Kahn, M. Raymondjean, 1994, The Journal of biological chemistry.

Functional characterization of the L-type pyruvate kinase gene glucose response complex

A. Kahn, M. Raymondjean, M. Cuif, 1993, Molecular and cellular biology.

Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments.

J. Chelly, A. Kahn, L. Poenaru, 1991, Genomics.

Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice

P. Briand, A. Kahn, T. Ragot, 1993, Nature.

In vivo regulation of glycolytic and gluconeogenic enzyme gene expression in newborn rat liver.

A. Munnich, S. Lyonnet, J. Girard, 1988, The Journal of clinical investigation.

Glucose-dependent Liver Gene Expression in Upstream Stimulatory Factor 2 −/− Mice*

S. Vaulont, A. Kahn, M. Raymondjean, 1997, The Journal of Biological Chemistry.

Dietary and hormonal regulation of L-type pyruvate kinase gene expression in rat small intestine.

A. Munnich, G. Reach, S. Lyonnet, 1987, European journal of biochemistry.

Tissue-specific heterogeneity of the 3'-untranslated region of L-type pyruvate kinase mRNAs.

J. Marie, A. Kahn, M. Cognet, 1986, European journal of biochemistry.

Purification of F4 phosphofructokinase from human platelets and comparison with the other phosphofructokinase forms.

A. Kahn, D. Cottreau, M. Meienhofer, 1980, Biochimica et biophysica acta.

Kinetic properties of human F4 phosphofructokinase

A. Kahn, J. Dreyfus, D. Cottreau, 1980, FEBS letters.

Activity and inducibility of drug-metabolizing enzymes in immortalized hepatocyte-like cells (mhPKT) derived from a L-PK/Tag1 transgenic mouse.

A. Kahn, A. Vandewalle, M. Bens, 1997, Experimental cell research.

Combinatorial crosstalk of transacting factors binding to the L-type pyruvate kinase promoter elements analysed in vitro.

S. Vaulont, A. Kahn, M. Raymondjean, 1992, Biochemical and biophysical research communications.

In vivo electrotransfer of the cardiotrophin-1 gene into skeletal muscle slows down progression of motor neuron degeneration in pmn mice.

A. Kahn, H. Gilgenkrantz, G. Haase, 2002, Human molecular genetics.

Functional Dissection of the Brain-specific Rat Aldolase C Gene Promoter in Transgenic Mice

A. Kahn, M. Thomas, M. Thomas, 1995, The Journal of Biological Chemistry.

Essential Role in Vivo of Upstream Stimulatory Factors for a Normal Dietary Response of the Fatty Acid Synthase Gene in the Liver*

S. Vaulont, A. Kahn, M. Casado, 1999, The Journal of Biological Chemistry.

Effect of different basic helix-loop-helix leucine zipper factors on the glucose response unit of the L-type pyruvate kinase gene.

L. Gourdon, A. Kahn, M. Raymondjean, 1998, Gene expression.

Cell-free translation of messenger RNAs from adult and fetal human muscle. Characterization of neosynthesized glycogen phosphorylase, phosphofructokinase and glucose phosphate isomerase.

A. Kahn, J. Dreyfus, D. Cottreau, 1981, European journal of biochemistry.

Bidirectional activity and orientation‐dependent specificity of the rat aldolase C promoter in transgenic mice

A. Kahn, A. Porteu, H. Skala, 2001, FEBS letters.

γ-Ray irradiation induces B7.1 costimulatory molecule neoexpression in various murine tumor cells

H. Haddada, A. Kahn, B. Polla,, 1998, Cancer Immunology, Immunotherapy.

Localization of the active gene of aldolase on chromosome 16, and two aldolase A pseudogenes on chromosomes 3 and 10

M. Gross, J. Frézal, A. Kahn, 1988, Human Genetics.

High tyrosine kinase activity in normal nonproliferating cells

A. Kahn, C. Rosenfeld, F. Tuy, 1983, Nature.

Analysis by cell-free transcription of the liver-specific pyruvate kinase gene promoter

S. Vaulont, A. Kahn, M. Raymondjean, 1989, Molecular and cellular biology.

The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2.

C. Junien, D. Weil, A. Kahn, 1984, American journal of human genetics.

Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4

B. Viollet, A. Kahn, M. Raymondjean, 1997, Molecular and cellular biology.

Cotranslation of L and L' pyruvate kinase messenger RNAs from human fetal liver.

J. Marie, A. Kahn, M. Simon, 1982, Biochimica et biophysica acta.

One gene, but two messenger RNAs encode liver L and red cell L′ pyruvate kinase subunits

J. Marie, A. Kahn, J. Dreyfus, 1981, Nature.

Phenotypic Alteration of Astrocytes Induced by Ciliary Neurotrophic Factor in the Intact Adult Brain, As Revealed by Adenovirus-Mediated Gene Transfer

M. Perricaudet, M. Peschanski, F. Lisovoski, 1997, The Journal of Neuroscience.

Upstream Elements Involved in Vivo in Activation of the Brain-specific Rat Aldolase C Gene

A. Kahn, M. Szajnert, H. Okazawa, 1998, The Journal of Biological Chemistry.

Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: Therapeutic effects and mechanisms of action

B. Pettmann, H. Schmalbruch, A. Kahn, 1998, Journal of the Neurological Sciences.

LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.

J. Dhainaut, P. Briand, V. Joulin, 1999, American journal of respiratory and critical care medicine.

Cloning and expression of cDNA for anti-müllerian hormone.

R. Benarous, A. Kahn, J. Picard, 1986, Proceedings of the National Academy of Sciences of the United States of America.

The Genes Coding for An-, Ba-, and -y-Chains of Fibrinogen Map to 4q2

J. Kaplan, A. Kahn, H. Nicolas, 2006 .

Molecular heterogeneity of McArdle disease

A. Kahn, S. Gautron, J. Dreyfus, 1986, Journal of Inherited Metabolic Disease.

Using adenoviral vectors to transfer the CNTF gene into the CNS.

M. Perricaudet, M. Peschanski, F. Lisovoski, 1995, Restorative Neurology and Neuroscience.

Severe iron deficiency anemia in transgenic mice expressing liver hepcidin

C. Beaumont, B. Grandchamp, S. Vaulont, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Brief report Hepcidin, a candidate modiﬁer of the hemochromatosis phenotype in mice

N. Andrews, S. Vaulont, A. Kahn, 2004 .

Exploration of a liver-specific, glucose/insulin-responsive promoter in transgenic mice.

S. Vaulont, A. Kahn, M. Cuif, 1993, The Journal of biological chemistry.

Therapeutic benefit of ciliary neurotrophic factor in progressive motor neuronopathy depends on the route of delivery

B. Pettmann, H. Schmalbruch, A. Kahn, 1999, Annals of neurology.

Advances in hereditary red cell enzyme anomalies

J. Kaplan, A. Kahn, J. Dreyfus, 2004, Human Genetics.

Determination of the gene structure of human oligophrenin-1 and identification of three novel polymorphisms by screening of DNA from 164 patients with non-specific X-linked mental retardation.

P. Billuart, J. Chelly, C. Moraine, 2000, Annales de genetique.

Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis

N. Andrews, C. Beaumont, S. Vaulont, 2003, Nature Genetics.

The brain-specific gene for rat aldolase C possesses an unusual housekeeping-type promoter.

A. Kahn, M. Vibert, H. Skala, 1989, European journal of biochemistry.

Molecular cloning and sequence analysis of cDNA for human transferrin.

M. Frain, A. Kahn, M. Zakin, 1984, Biochemical and biophysical research communications.

Characterization of proopiomelanocortin transcripts in human nonpituitary tissues.

X. Bertagna, A. Kahn, J. Luton, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Molecular cloning and expression of rat aldolase C messenger RNA during development and hepatocarcinogenesis.

F. Schweighoffer, A. Kahn, P. Maire, 1987, European journal of biochemistry.

Expression of aldolase A messenger RNAs in human adult and foetal tissues and in hepatoma.

F. Schweighoffer, A. Kahn, M. Levin, 1986, Biochemical and biophysical research communications.

Modifications of the expression of liver-specific and non-specific messenger RNAs during azo-dye hepatocarcinogenesis.

F. Schweighoffer, J. Marie, A. Kahn, 1985, European journal of biochemistry.

Nucleotide sequence of a cDNA clone for human aldolase B.

M. Frain, A. Kahn, M. Zakin, 1983, Biochemical and biophysical research communications.

Muscle as a putative producer of acid α-glucosidase for glycogenosis type II gene therapy

A. Orlacchio, C. Emiliani, A. Kahn, 2002 .

Inherited microdeletion in Xp21.3–22.1 involved in non‐specific mental retardation

G. Ponsot, J. Chelly, A. Kahn, 1998, Clinical genetics.

A gene for dominant nonspecific X-linked mental retardation is located in Xq28.

P. Billuart, G. Ponsot, J. Chelly, 1997, American journal of human genetics.

Identification by STS PCR screening of a microdeletion in Xp21.3-22.1 associated with non-specific mental retardation.

P. Billuart, J. Chelly, A. Kahn, 1996, Human molecular genetics.

Expression of the gene for anti-Müllerian hormone.

S. Mader, A. Kahn, J. Picard, 1990, Journal of reproduction and fertility.

Expression of c-myc is under dietary control in rat liver.

N. Denis, A. Kitzis, S. Lyonnet, 1987, Oncogene research.

Isolation and characterization of cDNA clones for human skeletal muscle alpha actin.

R. Heilig, A. Hanauer, A. Kahn, 1983, Nucleic acids research.

Upstream Stimulatory Factor Proteins Are Major Components of the Glucose Response Complex of the L-type Pyruvate Kinase Gene Promoter (*)

A. Kahn, M. Raymondjean, Antoine Martinez, 1995, The Journal of Biological Chemistry.

Glucose-dependent and -independent effect of insulin on gene expression.

A. Kahn, J. Decaux, O. Marcillat, 1991, The Journal of biological chemistry.

Variable modes of proopiomelanocortin gene transcription in human tumors.

X. Bertagna, A. Kahn, J. Luton, 1989, Molecular endocrinology.

The red-green visual pigment gene region in adrenoleukodystrophy.

H. Moser, J. Mandel, J. Kaplan, 1990, American journal of human genetics.

Functional and growth properties of a myometrial cell line derived from transgenic mice: effects of estradiol and antiestrogens.

A. Kahn, A. Vandewalle, M. Thomasset, 1996, Endocrinology.

Analysis of a brain-specific isozyme. Expression and chromatin structure of the rat aldolase C gene and transgenes.

J. Hardelin, P. Briand, A. Kahn, 1994, The Journal of biological chemistry.

RT-PCR and Gene Expression

J. Chelly, A. Kahn, C. Pinset, 1994 .

Early Steps of a Thymic Tumor in SV40 Transgenic Mice: Hyperplasia of Medullary Epithelial Cells and Increased Mature Thymocyte Numbers Disturb Thymic Export

A. Kahn, C. Godard, F. Vasseur, 2002, Developmental immunology.

Transimmortalized mouse intestinal cells (m-ICc12) that maintain a crypt phenotype.

S. Kernéis, A. Kahn, J. Kraehenbuhl, 1996, The American journal of physiology.

Molecular organization of human L' and L pyruvate kinases.

J. Marie, A. Kahn, O. Bertrand, 1982, Biochimica et biophysica acta.

Evidence for structural differences between human glucose-6-phosphate dehydrogenase purified from leukocytes and erythrocytes.

A. Kahn, O. Bertrand, P. Boivin, 1977, Biochemical and biophysical research communications.

Studies on the nature of different molecular forms of glucose-6-phosphate dehydrogenase purified from human leukocytes.

A. Kahn, O. Bertrand, P. Boivin, 1976, Biochimica et biophysica acta.

Glucose responsiveness of a reporter gene transduced into hepatocytic cells using a retroviral vector

Ruihuan Chen, A. Kahn, B. Doiron, 1995, FEBS letters.

Determinants of the brain-specific expression of the rat aldolase C gene: ex vivo and in vivo analysis.

P. Briand, A. Kahn, M. Thomas, 1993, European journal of biochemistry.

Elements responsible for hormonal control and tissue specificity of L-type pyruvate kinase gene expression in transgenic mice

S. Vaulont, A. Kahn, M. Cognet, 1992, Molecular and cellular biology.

Regulation of the multiple promoters of the human aldolase A gene: response of its two ubiquitous promoters to agents promoting cell proliferation.

V. Hakim, A. Kahn, P. Maire, 1991, Nucleic acids research.

Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes

A. Kahn, C. Mitchell, O. Soubrane, 1998, Nature Medicine.

Evidence for a postsynthetic proteolytic transformation of human erythrocyte pyruvate kinase into L‐type enzyme

H. Garreau, J. Marie, A. Kahn, 1977, FEBS letters.

Cellulose acetate electrophoresis of protein kinases: detection of the active forms using various substrates.

A. Kahn, A. Weber, D. Cottreau, 1982, Analytical biochemistry.

Fluorescence-assisted mismatch analysis (FAMA) for exhaustive screening of the α-galactosidase A gene and detection of carriers in Fabry disease

A. Kahn, T. Meo, M. Tosi, 1996, Human Genetics.

Cell-Free Translation of Messenger RNAs from Human Muscle Biopsies: a Miniaturized Tool for Investigation of Neuromuscular Diseases

A. Munnich, J. Marie, A. Kahn, 1982, Pediatric Research.

Characterization of messenger RNA for aldolase B in adult and fetal human liver.

A. Kahn, C. Besmond, J. Dreyfus, 1982, Biochemical and biophysical research communications.

Cell free synthesis of human prothrombin: immunological characterization of the translation product.

R. Benarous, A. Kahn, C. Besmond, 1981, Biochemical and biophysical research communications.

Dystrophin Gene Expression in Neuronal Tissues

J. Chelly, A. Kahn, 1992 .

Clone mammals... clone man?

A. Kahn, 1997, Nature.

Expression of MyoD1 coincides with terminal differentiation in determined but inducible muscle cells.

F. Gros, J. Chelly, A. Kahn, 1989, The EMBO journal.

Therapeutic beneﬁts of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy

J. Melki, A. Kahn, C. Cifuentes-Díaz, 2003 .

Functional Characterization oftheL-TypePyruvate Kinase GeneGlucose Response Complex MARIA-JOSEM.DIAZGUERRA,MARIE-ODILEBERGOT,ANTOINEMARTINEZ,

A. Kahn, Michelraymondjean, 1993 .

Regulated expression of mature human insulin in the liver of transgenic mice

X. Bertagna, Ruihuan Chen, A. Kahn, 1998, FEBS letters.

The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.

B. Viollet, M. Birnbaum, D. Carling, 2003, The Journal of clinical investigation.

Adenovirus-mediated transfer of the acid alpha-glucosidase gene into fibroblasts, myoblasts and myotubes from patients with glycogen storage disease type II leads to high level expression of enzyme and corrects glycogen accumulation.

A. Kahn, A. Reuser, E. Kremer, 1998, Human molecular genetics.

Transfer of a foreign gene into the brain using adenovirus vectors

M. Perricaudet, M. Peschanski, A. Kahn, 1993, Nature Genetics.

Expression of the transcripts initiated in the 62nd intron of the dystrophin gene

Y. Berwald‐Netter, A. Koulakoff, J. Hugnot, 1993, Neuromuscular Disorders.

Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice.

A. Kahn, C. Perret, A. Porteu, 1999, The American journal of physiology.

Posttranslational modifications of enzymes.

A. Kahn, J. Dreyfus, F. Schapira, 1978, Current topics in cellular regulation.

cis-acting DNA elements regulating expression of the liver pyruvate kinase gene in hepatocytes and hepatoma cells. Evidence for tissue-specific activators and extinguisher.

A. Kahn, M. Cognet, M. Bergot, 1991, Journal of Biological Chemistry.

Research on molecular mechanisms ofMcArdle's disease (muscle glycogen phosphorylase deficiency)

J. Marie, A. Kahn, A. Kahn, 1981 .

Insulin and cyclic AMP act at different levels on transcription of the L‐type pyruvate kinase gene

A. Kahn, M. Cuif, B. Doiron, 1997, FEBS letters.

Molecular cloning of cDNA for rat L-type pyruvate kinase and aldolase B.

J. Marie, P. Chaumet‐Riffaud, A. Kahn, 1983, The Journal of biological chemistry.

Intestinal Expression of the Calbindin-D9K Gene in Transgenic Mice

A. Kahn, A. Vandewalle, M. Thomasset, 1998, The Journal of Biological Chemistry.

Expression of the transferrin gene during development of non-hepatic tissues: high level of transferrin mRNA in fetal muscle and adult brain.

A. Kahn, M. Levin, G. Uzan, 1984, Biochemical and biophysical research communications.

Lymphoepithelial Interactions Trigger Specific Regulation of Gene Expression in the M Cell-Containing Follicle-Associated Epithelium of Peyer’s Patches1

A. Kahn, A. Vandewalle, M. Bens, 2002, The Journal of Immunology.

Characterization of human red blood cell tyrosine kinase.

A. Kahn, F. Phan-Dinh-Tuy, J. Henry, 1985, Biochemical and biophysical research communications.

Differences in the two red-cell populations in erythroleukaemia.

A. Kahn, P. Boivin, J. Hakim, 1971, Lancet.

Chicken Ovalbumin Upstream Promoter-Transcription Factor II, a New Partner of the Glucose Response Element of the L-type Pyruvate Kinase Gene, Acts as an Inhibitor of the Glucose Response*

D. Thomas, M. Vasseur-Cognet, L. Selig, 1999, The Journal of Biological Chemistry.

Gene transfer to schwann cells after peripheral nerve injury: A delivery system for therapeutic agents

C. Krarup, H. Schmalbruch, A. Kahn, 1998, Annals of neurology.

Pyruvate kinase isozymes in man

J. Marie, A. Kahn, P. Boivin, 1976, Human Genetics.

[23] Pyruvate kinases from human erythrocytes and liver

J. Marie, A. Kahn, 1982 .

Advances in Brief Intestinal Dysplasia and Adenoma in Transgenic Mice after Overexpression of an Activated b-Catenin 1

A. Kahn, M. Peuchmaur, A. Vandewalle, 1999 .

Protein kinases of rat liver during hepatocarcinogenesis induced by an azo dye.

A. Kahn, A. Weber, D. Cottreau, 1983, European journal of biochemistry.

Pulmonary Surfactant Protein A (SP-A) Is Expressed by Epithelial Cells of Small and Large Intestine (*)

A. Kahn, J. Bourbon, R. Ducroc, 1995, The Journal of Biological Chemistry.

Quantitative estimation of minor mRNAs by cDNA-polymerase chain reaction. Application to dystrophin mRNA in cultured myogenic and brain cells.

Y. Berwald‐Netter, J. Kaplan, J. Chelly, 1990, European journal of biochemistry.

CC Ar GG boxes, cis-acting elements with a dual specificity. Muscle-specific transcriptional activation and serum responsiveness.

A. Kahn, C. Pinset, D. Montarras, 1990, Journal of molecular biology.

Pyruvate Kinase and Phosphofructokinase Isozymes in Childhood Cancers

A. Kahn, C. Nezelof, M. Rousseau-Merck, 1982, Pediatric Research.

Post translational modifications of glucose-6-phosphate dehydrogenase in human leukemias.

A. Kahn, J. Bernard, P. Boivin, 1975, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Isozyme Pattern in Serially Xenotransplanted Childhood Tumors 1

A. Kahn, D. Cottreau, Marie-FranÃ, 2006 .

Phosphofructokinase in Human Fetus

A. Kahn, J. Dreyfus, D. Cottreau, 1980, Pediatric Research.

Phosphofructokinase in human blood cells.

G. Lenoir, A. Kahn, J. Dreyfus, 1979, Blood.

Purification and partial characterization of different forms of phosphofructokinase in man.

A. Kahn, M. Levin, D. Cottreau, 1979, Biochimica et biophysica acta.

The genetic system of the L-type pyruvate kinase forms in man. Subunit structure, interrelation and kinetic characteristics of the pyruvate kinase enzymes from erythrocytes and liver.

H. Garreau, J. Marie, A. Kahn, 1978, Biochimica et biophysica acta.

Two different species of messenger RNAs specify synthesis of M1 and M2 pyruvate kinase subunits.

A. Kahn, M. Levin, J. Dreyfus, 1982, Biochimica et biophysica acta.

Protein kinases in human leukemic cells

A. Kahn, J. Perrot, C. Boucheix, 1985, American journal of hematology.

Deletion of the long arm of the Y chromosome and review of Y chromosome abnormalities.

L Pinsky, A. Kahn, L. Pinsky, 1985, American journal of medical genetics.

Tyrosine kinases in normal human blood cells

A. Kahn, G. C. Varshney, F. Phan-Dinh-Tuy, 1986, FEBS letters.

Endogenous phosphorylation of soluble enzymes in human red cells. Cyclic 3',5'-AMP-dependent phosphorylation of phosphofructokinase without detectable regulatory effect.

Stefan Fischer, J. Marie, A. Kahn, 1980, Biochimica et biophysica acta.

Endogenous, cyclic 3'-5' AMP-dependent phosphorylation of human red cell pyruvate kinase.

J. Marie, A. Kahn, J. Dreyfus, 1979, Biochemical and biophysical research communications.

Genetic and epigenetic control of the pyruvate kinase isozymes in mammals.

J. Marie, A. Kahn, M. Levin, 1983, Isozymes.

Phosphofructokinase (PFK) isozymes in man

A. Kahn, J. Dreyfus, D. Cottreau, 1979, Human Genetics.

Characterization of three optional promoters in the 5' region of the human aldolase A gene.

V. Hakim, A. Kahn, P. Maire, 1987, Journal of molecular biology.

Detection of mRNAs present at low concentrations in rat liver by in situ hybridization: application to the study of metabolic regulation and azo dye hepatocarcinogenesis.

A. Guillouzo, A. Kahn, E. Lamas, 1987, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Gene expression in hepatocyte-like lines established by targeted carcinogenesis in transgenic mice.

P. Briand, A. Kahn, T. Berbar, 1992, Experimental cell research.

Isozyme shift in cultured fetal human hepatocytes: a study of pyruvate kinase and phosphofructokinase.

J. Marie, C. Guguen-Guillouzo, A. Kahn, 1980, Biochemical and biophysical research communications.

Pyruvate kinase isozymes in man

J. Marie, A. Kahn, P. Boivin, 1976, Human Genetics.

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.

M. Buendia, P. Billuart, J. Chelly, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Molecular mechanism of erythrocyte pyruvate kinase deficiency

J. Marie, A. Kahn, P. Boivin, 1975, Humangenetik.

Chronic haemolytic anaemia in two patients heterozygous for erythrocyte pyruvate kinase deficiency. Electrofocusing and immunological studies of erythrocyte and liver pyruvate kinase.

J. Marie, A. Kahn, P. Boivin, 2009, Scandinavian journal of haematology.

Adenoviral gene therapy of the Tay-Sachs disease in hexosaminidase A-deficient knock-out mice.

N McDonell, A. Kahn, C. Caillaud, 1999, Human molecular genetics.

Neuronal expression of enhanced green fluorescent protein directed by 5′ flanking sequences of the rat aldolase C gene in transgenic mice

A. Kahn, E. Souil, F. Phan-Dinh-Tuy, 2003, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

Characterization of the Aldolase B Intronic Enhancer*

A. Kahn, A. Porteu, A. Pichard, 1998, The Journal of Biological Chemistry.

Gd(-) Abrami a deficient G-6PD variant with hemizygous expression in blood cells of a woman with primary myelofibrosis

J. Marie, A. Kahn, J. Bernard, 1975, Humangenetik.

Hyperanodic forms of human glucose-6-phosphate dehydrogenase.

A. Kahn, J. Dreyfus, D. Cottreau, 1978, Biochimica et biophysica acta.

Causal mechanisms of multiple acquired red cell enzyme defects in a patient with acquired dyserythropoiesis.

J. Marie, A. Kahn, P. Boivin, 1976, Blood.

Mechanisms of the acquired erythrocyte enzyme deficiencies in blood diseases.

J. Marie, A. Kahn, J. Bernard, 1976, Clinica chimica acta; international journal of clinical chemistry.

Illegitimate transcription: Its use in the study of inherited disease

Jamel Chelly, J. Kaplan, J. Chelly, 1992, Human mutation.

Proteolytic processing of human erythrocyte pyruvate kinase : study of normal and deficient enzymes.

J. Marie, A. Kahn, 1979, Biochemical and biophysical research communications.

Transcription of the dystrophin gene in human muscle and non-muscle tissues

Jamel Chelly, Pascal Maire, J. Kaplan, 1988, Nature.

A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation

Lin Jun, Peter Marynen, Mark T. Ross, 1999, Nature Genetics.

Doublecortin Is a Developmentally Regulated, Microtubule-Associated Protein Expressed in Migrating and Differentiating Neurons

S. Mcconnell, Y. Berwald‐Netter, B. Schaar, 1999, Neuron.

Targeted oncogenesis: A powerful method to derive renal cell lines.

P. Briand, A. Kahn, A. Vandewalle, 1995, Kidney international.

The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver

M. Buendia, A. Kahn, C. Neuveut, 2002, Oncogene.

The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Gaël Nicolas, Isabelle Devaux, C. Beaumont, 2002, The Journal of clinical investigation.

Bcl-2 and Bax modulate adenine nucleotide translocase activity.

M. Prevost, G. Kroemer, P. Petit, 2003, Cancer research.

The 'CC.Ar.GG' box. A protein-binding site common to transcription-regulatory regions of the cardiac actin, c-fos and interleukin-2 receptor genes.

A. Minty, F. Schweighoffer, A. Kahn, 1988, European journal of biochemistry.

Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit.

B. Viollet, H. Sul, S. Vaulont, 2004, Diabetes.

5'-Flanking and Intragenic Sequences Confer Androgenic and Developmental Regulation of Mouse Aldose Reductase-Like Gene in Vas Deferens and Adrenal in Transgenic Mice.

A. Kahn, Antoine Martinez, M. Manin, 1999, Endocrinology.

Apc tumor suppressor gene is the "zonation-keeper" of mouse liver.

D. Rickman, M. Vasseur-Cognet, C. Kuo, 2006, Developmental cell.

Novel Target Sequences for Pax-6 in the Brain-specific Activating Regions of the Rat Aldolase C Gene*

A. Kahn, V. Labas, J. Vinh, 2002, The Journal of Biological Chemistry.

Identification of the IFITM family as a new molecular marker in human colorectal tumors.

P. Laurent-Puig, A. Kahn, S. Colnot, 2006, Cancer research.

Transcriptional and post-transcriptional regulation of L-type pyruvate kinase gene expression in rat liver.

A. Munnich, S. Vaulont, A. Kahn, 1986, The Journal of biological chemistry.

Mapping of the X-Breakpoint Involved in a Balanced X;12 Translocation in a Female with Mild Mental Retardation

P. Billuart, D. Cohen, J. Chelly, 1997, European journal of human genetics : EJHG.

Sequences complementary to the brain-specific "identifier" sequences exist in L-type pyruvate kinase mRNA (a liver-specific messenger) and in transcripts especially abundant in muscle.

J. Marie, A. Kahn, Y. Lone, 1986, The Journal of biological chemistry.

Mouse USF1 gene cloning: comparative organization within the c-myc gene family

S. Vaulont, A. Kahn, M. Raymondjean, 1996, Mammalian Genome.

Transcriptional control of metabolic regulation genes by carbohydrates

S. Vaulont, A. Kahn, 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice

B. Viollet, V. Joulin, A. Kahn, 1996, Nature Medicine.

Assignment of the ǵene for F‐type phosphofructokinase to human chromosome 10 by somatic cell hybridization and specific immunoprecipitation

M. Gross, D. Weil, A. Kahn, 1980, Annals of human genetics.

Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site.

J. Concordet, F. Spitz, A. Kahn, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice

C. Beaumont, B. Grandchamp, S. Vaulont, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Immunochemical Characterization and Transacting Properties of Upstream Stimulatory Factor Isoforms (*)

B. Viollet, A. Kahn, M. Raymondjean, 1996, The Journal of Biological Chemistry.

A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation

A. Meindl, H. Ropers, R. Sudbrak, 2000, Nature Genetics.

Structure of the rat L-type pyruvate kinase gene.

J. Marie, S. Vaulont, A. Kahn, 1987, Journal of molecular biology.

Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.

M. Giovannini, A. Kahn, G. Hamard, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Heat lability of glucose-6-phosphate dehydrogenase in some senescent human cultured cells. Evidence for its postsynthetic nature.

A. Guillouzo, M. Bourel, M. Leibovitch, 1977, Biochemical and biophysical research communications.

An Intronic Enhancer Essential for Tissue-specific Expression of the Aldolase B Transgenes (*)

J. Sabourin, A. Kahn, A. Porteu, 1996, The Journal of Biological Chemistry.

Fas/CD95 pathway induces mouse liver regeneration and allows for highly efficient retrovirus‐mediated gene transfer

A. Kahn, V. Mallet, C. Mitchell, 2001, Hepatology.

Modifications of phosphoproteins and protein kinases occurring with in vitro aging of cultured human cells.

A. Guillouzo, G. Baffet, A. Kahn, 1982, Gerontology.

In vivo transfer of a marker gene to study motoneuronal development.

M. Peschanski, F. Lisovoski, A. Kahn, 1994, Neuroreport.

Pro-opiomelanocortin gene expression in human phaeochromocytomas.

X. Bertagna, A. Kahn, J. Luton, 1989, Journal of molecular endocrinology.

A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease.

J. Chelly, A. Kahn, C. Mézard, 1990, The Journal of biological chemistry.

Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice.

N. Andrews, H. Bujard, K. Schönig, 2006, Blood.

Iron‐ and inflammation‐induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo

L. Rénia, S. Vaulont, A. Kahn, 2005, Hepatology.

Hepcidin, a new iron regulatory peptide.

C. Beaumont, S. Vaulont, A. Kahn, 2002, Blood cells, molecules & diseases.

Fiber-type specific and position-dependent expression of a transgene in limb muscles.

J. Sabourin, F. Spitz, A. Kahn, 2002, Differentiation; research in biological diversity.

Therapeutic liver repopulation in a mouse model of hypercholesterolemia.

A. Kahn, A. Tedgui, C. Mitchell, 2000, Human molecular genetics.

Somatic mutations of the b -catenin gene are frequent in mouse and human hepatocellular carcinomas

P. Billuart, J. Chelly, A. Kahn, 1998 .

Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis.

S. Vaulont, A. Kahn, G. Hamard, 2006, Blood.

Retroviral infection of primary hepatocytes from normal mice and mice transgenic for SV40 large T antigen.

P. Briand, A. Kahn, J. Decaux, 1993, Experimental cell research.

Hepatomegaly in Transgenic Mice Expressing an Oncogenic Form of β-Catenin

A. Cadoret, A. Kahn, E. Souil, 2001 .

A combination of MEF3 and NFI proteins activates transcription in a subset of fast-twitch muscles

F. Spitz, A. Kahn, M. Salminen, 1997, Molecular and cellular biology.

Expression of the rat L-type pyruvate kinase gene from its dual erythroid- and liver-specific promoter in transgenic mice.

A. Kahn, J. Jami, M. Cognet, 1989, The Journal of biological chemistry.

Establishment of renal proximal tubule cell lines by targeted oncogenesis in transgenic mice using the L-pyruvate kinase-SV40 (T) antigen hybrid gene.

P. Briand, A. Kahn, J. Hagège, 1993, Journal of cell science.

Functional properties of proximal tubule cell lines derived from transgenic mice harboring L-pyruvate kinase-SV40 (T) antigen hybrid gene.

A. Kahn, A. Vandewalle, M. Bens, 1993, Journal of cell science.

DNase-I hypersensitivity analysis of the L-type pyruvate kinase gene in rats and transgenic mice.

S. Vaulont, A. Kahn, M. Raymondjean, 1992, European journal of biochemistry.

Elements Responsible forHormonal Control andTissue Specificity ofL-TypePyruvate Kinase Gene Expression inTransgenic Mice

A. Kahn, G. Tremp, Sophievaulont, 1992 .

Positive and negative regulation of gene expression by insulin and glucagon: the model of L-type pyruvate kinase gene.

S. Vaulont, A. Kahn, M. Raymondjean, 1991, Biochimie.

In vivo hormonal control of L-type pyruvate kinase gene expression. Effects of glucagon, cyclic AMP, insulin, cortisone, and thyroid hormones on the dietary induction of mRNAs in the liver.

A. Munnich, G. Reach, J. Marie, 1984, The Journal of biological chemistry.

Differential Roles of Upstream Stimulatory Factors 1 and 2 in the Transcriptional Response of Liver Genes to Glucose*

S. Vaulont, A. Kahn, M. Raymondjean, 1998, The Journal of Biological Chemistry.

G6PD Vientiane: A new glucose-6-phosphate dehydrogenase variant with increased stability

A. Kahn, F. Oberling, J. Lang, 1978, Human Genetics.

Metachromatic leukodystrophy: Identification of the first deletion in exon 1 and nine novel point mutations in the arylsulfatase A gene

A. Kahn, C. Caillaud, F. Letourneur, 1997, Human mutation.

Interplay of an original combination of factors: C/EBP, NFY, HNF3, and HNF1 in the rat aldolase B gene promoter.

A. Kahn, M. Raymondjean, F. Ginot, 1991, Nucleic acids research.

Non-specific X-linked semidominant mental retardation by mutations in a Rab GDP-dissociation inhibitor.

P. Billuart, J. Fryns, H. van Bokhoven, 1998, Human molecular genetics.

Gd(minus)Matam, an African glucose-6-phosphate dehydrogenase variant with enzyme deficiency. Biochemical and immunological properties in various hemopoietic tissues.

A. Kahn, P. Boivin, D. Cottreau, 1975, Clinica chimica acta; international journal of clinical chemistry.

Post-translational modifications of human glucose-6-phosphate dehydrogenase.

A. Kahn, P. Boivin, J. Dreyfus, 1975, Biochimie.

G6PD deficiency with Gd(-)A like variant in a Chinese family from Cambodia

B. Dastugue, A. Kahn, D. Cottreau, 1979, Human Genetics.

‘GPI Roma’, a new glucose phosphate isomerase deficient variant

F. Mandelli, G. Papa, A. Kahn, 1979, Human Genetics.

‘Gd(-) Hôtel Dieu’: A new G-6PD variant with chronic hemolysis in a Negro patient from Senegal

A. Kahn, D. Cottreau, C. Dao, 1977, Human Genetics.

GD (-) Aachen, a new variant of deficient glucose-6-phosphate dehydrogenase

A. Kahn, M. Habedank, A. Esters, 1976, Human Genetics.

[Phenotypes of erythrocytic glucose-6-phosphate dehydrogenase in black people. Examination of 301 black people living in France and description of 9 different variants. High incidence of deficiency of an enzyme of "B" mobility].

A. Kahn, P. Boivin, J. Lagneau, 1973, Humangenetik.

Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients.

A. Kahn, L. Bachner, J. Chomel, 1993, Human molecular genetics.

Glucose-6-phosphate dehydrogenase Velletri.

F. Mandelli, G. Papa, A. Kahn, 1977, Acta haematologica.

G-6PD “ankara”. A new G-6PD variant with deficiency found in a Turkish family

A. Kahn, J. Messer, P. Boivin, 2004, Humangenetik.

Molecular mechanism of glucose-6-phosphate dehydrogenase deficiency

A. Kahn, P. Boivin, D. Cottreau, 2004, Humangenetik.

Identification of different molecules leading to the formation of hyperanodic forms of human glucose-6-phosphate dehydrogenase.

A. Kahn, J. Dreyfus, M. Vibert, 1981, Biochemical and biophysical research communications.

Phospho ADP ribosylation of human glucose 6 phosphate dehydrogenase: probable mechanism of the occurrence of hyperanodic forms.

A. Kahn, J. Dreyfus, M. Vibert, 1979, Biochemical and biophysical research communications.

Human leukocyte glucose-phosphate-isomerase purification by affinity elution and immunological study.

A. Kahn, O. Bertrand, P. Boivin, 1976, Biochimie.

Human granulocyte 6 phosphogluconate dehydrogenase. Purification by elective elution with NADP+, immunological and kinetic properties.

J. Marie, A. Kahn, P. Boivin, 1975, Biochimie.

Favism in a Portuguese family due to a deficient glucose-phosphate dehydrogenase variant (Canton) or (cpanton-like) type.

J. Marie, A. Kahn, P. Boivin, 1976, Acta haematologica.

Glucose-6-phosphate dehydrogenase slow variant with deficiency in a Spanish family. Relationship with the Gd (minus) Seattle variant.

A. Kahn, P. Boivin, D. Cottreau, 1974, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Molecular and functional anomalies in two new mutant glucose-phosphate-isomerase variants with enzyme deficiency and chronic hemolysis

C. Griscelli, A. Kahn, R. Girot, 1978, Human Genetics.

Glucose phosphate isomerase deficiency with hereditary hemolytic anemia in a Spanish family: Clinical and familial studies

A. Kahn, C. Rozman, J. Triginer, 1975, Humangenetik.

Genetic and Molecular Mechanisms of the Congenital Defects in Glucose Phosphate Isomerase Activity: Studies of Four Families

A. Kahn, J. P. Biervliet, D. Cottreau, 1977, Pediatric Research.

Glucose-phosphate isomerase deficiency due to a new variant (GP I Barcelona) and to a silent gene: biochemical, immunological and genetic studies.

J. Marie, A. Kahn, O. Bertrand, 1976, Clinica chimica acta; international journal of clinical chemistry.

Red cell enzymopathies: molecular mechanisms.

A. Kahn, J. Dreyfus, A. Kahn, 1984, Clinical biochemistry.

Hereditary erythrocyte pyruvate-kinase (PK) deficiency and chronic hemolytic anemia: Clinical, genetic and molecular studies in six new Spanish patients

J. Marie, A. Kahn, M. Pujades, 1980, Human Genetics.

Of mice and men: the iron age.

S. Vaulont, A. Kahn, D. Lou, 2005, The Journal of clinical investigation.

Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice.

N. Andrews, S. Vaulont, A. Kahn, 2004, Blood.

Acquired red cell pyruvate kinase deficiency in leukemias and related disorders.

A. Kahn, P. Boivin, C. Galand, 1975, Enzyme.

Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies

A. Chapelle, M. Koenig, J. Kaplan, 1990, Cell.

Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues.

A. Monaco, Y. Berwald‐Netter, A. Koulakoff, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Growth and differentiation of C2 myogenic cells are dependent on serum response factor

A. Kahn, N. Lautrédou, C. Rouvière, 1996, Molecular and cellular biology.

CFTR illegitimate transcription in lymphoid cells: quantification and applications to the investigation of pathological transcripts

A. Kitzis, J. Kaplan, J. Chelly, 1992, Human Genetics.

Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients.

J. Hugnot, J. Kaplan, J. Chelly, 1991, The Journal of clinical investigation.

Illegitimate (or ectopic) transcription proceeds through the usual promoters.

J. Hugnot, J. Concordet, J. Kaplan, 1991, Biochemical and biophysical research communications.

Developmental regulation of the aldolase A muscle-specific promoter during in vivo muscle maturation is controlled by a nuclear receptor binding element.

F. Spitz, A. Kahn, J. Demignon, 1999, Journal of molecular biology.

Proximal Sequences of the Aldolase A Fast Muscle-specific Promoter Direct Nerve- and Activity-dependent Expression in Transgenic Mice*

F. Spitz, A. Kahn, J. Demignon, 1998, The Journal of Biological Chemistry.

A Binding Site for Nuclear Receptors Is Required for the Differential Expression of the Aldolase A Fast-twitch Muscle Promoter in Body and Head Muscles*

J. Sabourin, F. Spitz, A. Kahn, 1998, The Journal of Biological Chemistry.

Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome.

B. Knebelmann, A. Kahn, J. Picard, 1991, Proceedings of the National Academy of Sciences of the United States of America.

The Na‐G Ion Channel Is Transcribed from a Single Promoter Controlled by Distinct Neuron‐ and Schwann Cell‐Specific DNA Elements

A. Kahn, C. Gruszczynski, S. Gautron, 1999, Journal of neurochemistry.

Influence of the content in transcription factors on the phenotype of mouse hepatocyte-like cell lines (mhAT).

A. Kahn, T. Berbar, F. Levrat, 1993, Experimental cell research.

Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the β-catenin gene

A. Kahn, M. Peuchmaur, A. Vandewalle, 2001, Oncogene.

Fast-muscle-specific expression of human aldolase A transgenes

A. Kahn, M. Salminen, P. Maire, 1994 .

Fast-muscle-specific expression of human aldolase A transgenes.

J. Concordet, A. Kahn, M. Salminen, 1994, Molecular and cellular biology.

The pyruvate kinase gene as a model for studies of glucose-dependent regulation of gene expression in the endocrine pancreatic beta-cell type.

A. Kahn, P. Iynedjian, M. Diaz-Guerra, 1993, The Journal of biological chemistry.

Proteins binding to the liver-specific pyruvate kinase gene promoter. A unique combination of known factors.

S. Vaulont, A. Kahn, M. Raymondjean, 1989, Journal of molecular biology.

Pyruvate kinases from human erythrocytes and liver.

J. Marie, A. Kahn, 1982, Methods in enzymology.

Functional differences between hepcidin 1 and 2 in transgenic mice.

G. Grimber, S. Vaulont, A. Kahn, 2004, Blood.

On the evolutionary conservation of the cell death pathway: mitochondrial release of an apoptosis-inducing factor during Dictyostelium discoideum cell death.

P. Petit, A. Kahn, J. Estaquier, 2001, Molecular biology of the cell.

Structure, sequence, and chromosomal location of the gene for USF2 transcription factors in mouse.

M. Mattei, A. Kahn, M. Raymondjean, 1995, Genomics.

Characterization of the rat pulmonary surfactant protein A promoter.

C. Fraslon, A. Kahn, M. Raymondjean, 1992, European journal of biochemistry.

Gene delivery into the central nervous system by nasal instillation in rats.

A. Kahn, A. Pavirani, C. Caillaud, 1995, Gene therapy.

Complete nucleotide and deduced amino acid sequences of rat L‐type pyruvate kinase

J. Marie, A. Kahn, Y. Lone, 1986, FEBS letters.

Striking conservation of the brain-specific region of the dystrophin gene

J. Hugnot, J. Kaplan, J. Chelly, 2004, Mammalian Genome.

The structural gene for aldolase B (ALDB) maps to 9q13→32

C. Junien, D. Weil, M. Mattei, 1985, Annals of human genetics.

Molecular Heterogeneity of MArdle's Disease

A. Kahn, S. Gautron, J. Dreyfus, 1986 .

Expression of the dystrophin gene in cultured fibroblasts.

J. Hugnot, E. Eveno, J. Kaplan, 1993, Biochemical and biophysical research communications.

Independence and interdependence of the three human aldolase A promoters in transgenic mice.

A. Kahn, C. Moch, D. Daegelen, 1996, Gene expression.

Adenovirus-mediated transfer of a human dystrophin gene to skeletal muscle of mdx mouse.

J. Kaplan, P. Briand, A. Kahn, 1994, Gene therapy.

Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry.

B. Bloch, A. Kahn, M. Levin, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas' heart disease.

R. Benarous, A. Kahn, M. Levin, 1989, The American journal of tropical medicine and hygiene.

Activity of the rat liver-specific aldolase B promoter is restrained by HNF3.

A. Kahn, A. Pichard, C. Grégori, 1994, Nucleic acids research.

Dominant X linked subcortical laminar heterotopia and lissencephaly syndrome (XSCLH/LIS): evidence for the occurrence of mutation in males and mapping of a potential locus in Xq22.

D. Smadja, P. Billuart, O. Dulac, 1997, Journal of medical genetics.

The structural gene for transferrin (TF) maps to 3q21----3qter.

K. Grzeschik, C. Junien, D. Weil, 1984, Annales de genetique.

Fructose‐1,6‐diphosphate binding by two forms of pyruvate kinase purified from human erythrocytes

H. Garreau, J. Marie, A. Kahn, 1977, FEBS letters.

Search for a relationship between molecular anomalies of the mutant erythrocyte pyruvate kinase variants and their pathological expression

J. Marie, A. Kahn, A. Najman, 2004, Human Genetics.

Immunologie Study of the Age-related Loss of Activity of Six Enzymes in the Red Cells from Newborn Infants and Adults — Evidence for a Fetal Type of Erythrocyte Phosphofructokinase

J. Marie, A. Kahn, P. Boivin, 1977, Pediatric Research.

Significance of the electrophoretic modifications of defective pyruvate kinase variants. Study of six new observations.

A. Zanella, J. Marie, A. Kahn, 1979, Clinica chimica acta; international journal of clinical chemistry.

Hereditary erythrocyte pyruvate kinase deficiency: molecular and functional studies of four mutant PK variants detected in Spain.

J. Marie, A. Kahn, J. L. Vives-Corrons, 1977, Clinica chimica acta; international journal of clinical chemistry.

A Spanish family with erythrocyte pyruvate kinase deficiency: contribution of various immunologic methods in the study of the mutant enzyme.

J. Marie, A. Kahn, P. Boivin, 1977, Clinica chimica acta; international journal of clinical chemistry.

Proteolytic processing of human L-type pyruvate kinase increases its ability to be phosphorylated.

J. Marie, A. Kahn, 1980, Biochemical and biophysical research communications.

Human erythrocyte pyruvate kinase. Total purification and evidence for its antigenic identity with L-type enzyme.

J. Marie, A. Kahn, P. Boivin, 1977, Biochimica et biophysica acta.

Purification of L-type pyruvate kinase from human liver by affinity chromatography on Blue-Dextran-Sepharose column.

J. Marie, A. Kahn, 1977, Enzyme.

Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice.

H. Schmalbruch, A. Kahn, G. Haase, 2001, Human molecular genetics.

Induction of glycolytic enzyme synthesis in proliferating fibroblasts. Study of phosphofructokinase, glucose phosphate isomerase and pyruvate kinase.

A. Kahn, J. Dreyfus, M. Meienhofer, 1983, The Biochemical journal.

Dietary control of aldolase B and L-type pyruvate kinase mRNAs in rat. Study of translational activity and hybridization with cloned cDNA probes.

J. Marie, A. Kahn, A. Weber, 1984, The Journal of biological chemistry.

New targets of β-catenin signaling in the liver are involved in the glutamine metabolism

Jan Kitajewski, Benoit Terris, A. Cadoret, 2002, Oncogene.

Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II.

J. Kaplan, A. Kahn, L. Vieira, 1995, Blood.

Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver.

B. Viollet, M. Foretz, F. Andreelli, 2005, Diabetes.

Isozyme pattern in serially xenotransplanted childhood tumors.

A. Kahn, M. Rousseau-Merck, D. Cottreau, 1984, Cancer research.

The human pH aldolase A promoter directs widespread but muscle-predominant expression in transgenic mice

F. Spitz, A. Kahn, A. Porteu, 1998, Transgenic Research.

Activation of gene expression via CArG boxes during myogenic differentiation.

A. Kahn, C. Pinset, D. Montarras, 1993, Experimental Cell Research.

Liver repopulation by Bcl-x(L) transgenic hepatocytes.

A. Kahn, V. Mallet, C. Mitchell, 2002, The American journal of pathology.

Glycogen-storage disease type II (acid maltase deficiency): identification of a novel small deletion (delCC482+483) in French patients.

A. Kahn, M. Fardeau, M. Nicolino, 1997, Biochemical and biophysical research communications.

Essential role of chicken ovalbumin upstream promoter-transcription factor II in insulin secretion and insulin sensitivity revealed by conditional gene knockout.

M. Vasseur-Cognet, Y. Le Marchand-Brustel, J. Tanti, 2005, Diabetes.

Msp1 RFLP in the human hexosaminidase beta peptide (Hex B) gene.

A. Kahn, L. Poenaru, L. Castelnau, 1989, Nucleic acids research.

Phosphorylation of Human Erythrocyte Pyruvate Kinase by Soluble Cyclic-AMP-Dependend Protein Kinases

J. Marie, A. Kahn, H. Buc, 1980 .

Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.

A. Cadoret, A. Kahn, E. Souil, 2001, Cancer research.

Gene for nonspecific X-linked mental retardation (MRX 47) is located in Xq22.3-q24.

P. Billuart, G. Ponsot, J. Chelly, 1997, American journal of medical genetics.

Phosphorylation of human erythrocyte pyruvate kinase by soluble cyclic-AMP-dependent protein kinases. Comparison with human liver L-type enzyme.

J. Marie, A. Kahn, H. Buc, 1980, European journal of biochemistry.

Myotube-specific activity of the human aldolase A M-promoter requires an overlapping binding site for NF1 and MEF2 factors in addition to a binding site (M1) for unknown proteins.

M. Fiszman, F. Spitz, A. Kahn, 1995, Journal of molecular biology.

In vitro and in vivo protein--DNA interactions on the rat erythroid-specific L' pyruvate kinase gene promoter.

A. Kahn, M. Raymondjean, S. López, 1992, Nucleic acids research.

Transcription factors and aldolase B gene expression in microdissected renal proximal tubules and derived cell lines.

A. Kahn, F. Levrat, A. Vandewalle, 1995, Experimental cell research.

Muscle as a putative producer of acid alpha-glucosidase for glycogenosis type II gene therapy.

A. Orlacchio, C. Emiliani, A. Kahn, 2002, Human molecular genetics.

In vivo developmental modifications of the expression of genes encoding muscle-specific enzymes in rat.

F. Schweighoffer, A. Kahn, L. Bachner, 1986, The Journal of biological chemistry.

Analysis of fibrinogen genes in patients with congenital afibrinogenemia.

G. Courtois, M. Frain, A. Kahn, 1984, Biochemical and biophysical research communications.

Erythrocyte phosphofructokinase deficiency associated with an unstable variant of muscle phosphofructokinase.

A. Kahn, M. Meienhofer, J. Etiemble, 1975, Clinica chimica acta; international journal of clinical chemistry.

Transferrin gene expression in choroid plexus of the adult rat brain

B. Bloch, A. Kahn, M. Levin, 1987, Brain Research Bulletin.

Competition between transcription factors HNF1 and HNF3, and alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase B promoter.

A. Kahn, A. Pichard, C. Grégori, 1993, Nucleic acids research.

Regulation of genes for glycolytic enzymes in cultured rat hepatoma cell lines.

A. Kahn, M. Cognet, E. Médicis, 1987, European journal of biochemistry.

Advances in hereditary red cell enzyme abnormalities.

A. Kahn, 1979, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Advances in Brief Hepatomegaly in Transgenic Mice Expressing an Oncogenic Form of b-Catenin 1

A. Cadoret, A. Kahn, E. Souil, 2001 .

Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.

M. Perricaudet, A. Kahn, E. Vigne, 1996, Gene therapy.

In vivo effects of activated H-ras oncogene expressed in the liver and in urogenital tissues.

M. Tulliez, F. Terzi, A. Kahn, 1997, International journal of cancer.

[Values and limits of adenoviral vectors for gene transfer in vivo].

P. Briand, A. Kahn, 1993, Pathologie et biologie.

DNA analysis in patients with hereditary fructose intolerance

A. Kahn, M. Odiévre, C. Besmond, 1984, Annals of human genetics.

Molecular studies of liver aldolase B in hereditary fructose intolerance using blotting and immunological techniques

A. Kahn, M. Delpech, J. Dreyfus, 1982, Annals of human genetics.

Skipping of exon 5 as a consequence of the 711 + 1 G-->T mutation in the CFTR gene.

A. Kitzis, J. Kaplan, A. Kahn, 1992, Human molecular genetics.

Cyclic AMP as a transcriptional inhibitor of upper eukaryotic gene transcription.

A. Munnich, G. Reach, P. Barbry, 1984, Biochemical and biophysical research communications.

Protein kinases in normal human blood cells

A. Kahn, C. Rosenfeld, F. Tuy, 1983, American journal of hematology.

Positive and negative regulatory DNA elements including a CCArGG box are involved in the cell type-specific expression of the human muscle dystrophin gene.

J. Hugnot, J. Kaplan, A. Kahn, 1992, The Journal of biological chemistry.

Transient transcriptional inhibition of the transferrin gene by cyclic AMP

A. Munnich, P. Brissot, S. Vaulont, 1985, FEBS letters.

X-linked neurodegenerative syndrome with congenital ataxia, late-onset progressive myoclonic encephalopathy and selective macular degeneration, linked to Xp22.33-pter.

E. Bertini, P. Billuart, J. Chelly, 1996, American journal of medical genetics.

Immunological screening of standard cDNA libraries in pBR322 vectors: detection of human fibrinogen and prothrombin cDNA clones.

R. Benarous, M. Frain, A. Kahn, 1984, Analytical biochemistry.

Human erythrocyte phosphoglycerate kinase deficiency: presence in a deficient patient of a stable variant with lowered catalytic activity.

A. Kahn, P. Boivin, C. Galand, 1976, Clinica chimica acta; international journal of clinical chemistry.

Control of Hepatic Gene Expression at Both Transcriptional and Posttranscriptional Levels by cAMP

A. Munnich, S. Vaulont, A. Kahn, 1986 .

Research on molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). Use of new protein mapping and immunological techniques.

J. Marie, A. Kahn, J. Dreyfus, 1981, Annals of human genetics.